Patents Assigned to Noorik Biopharmaceuticals AG
  • Treatment of portal hypertension and cirrhosis
    Patent number: 11883400
    Abstract: Methods and formulations are provided for the treatment and prevention of portal hypertension.
    Type: Grant
    Filed: October 21, 2019
    Date of Patent: January 30, 2024
    Assignee: Noorik Biopharmaceuticals AG
    Inventor: Iker Navarro
  • AMBRISENTAN FOR USE IN THE TREATMENT OF ACUTE RENAL FAILURE
    Publication number: 20230233454
    Abstract: Ambrisentan and formulations thereof for use in the treatment and prevention of acute renal failure associated with renal vasoconstriction.
    Type: Application
    Filed: March 31, 2023
    Publication date: July 27, 2023
    Applicant: Noorik Biopharmaceuticals AG
    Inventors: Iker Navarro, Satish KHANNA
  • Ambrisentan for use in the treatment of acute renal failure
    Patent number: 11642307
    Abstract: Ambrisentan and formulations thereof for use in the treatment and prevention of acute renal failure associated with renal vasoconstriction.
    Type: Grant
    Filed: October 7, 2020
    Date of Patent: May 9, 2023
    Assignee: Noorik Biopharmaceuticals AG
    Inventor: Iker Navarro
  • TREATMENT OF PORTAL HYPERTENSION AND CIRRHOSIS
    Publication number: 20210338667
    Abstract: Methods and formulations are provided for the treatment and prevention of portal hypertension.
    Type: Application
    Filed: October 21, 2019
    Publication date: November 4, 2021
    Applicant: Noorik Biopharmaceuticals AG
    Inventor: Iker NAVARRO
  • AMBRISENTAN FOR USE IN THE TREATMENT OF ACUTE RENAL FAILURE
    Publication number: 20210046332
    Abstract: Ambrisentan and formulations thereof for use in the treatment and prevention of acute renal failure associated with renal vasoconstriction.
    Type: Application
    Filed: October 7, 2020
    Publication date: February 18, 2021
    Applicant: Noorik Biopharmaceuticals AG
    Inventors: Iker NAVARRO, Satish KHANNA
  • Ambrisentan for use in the treatment of acute renal failure
    Patent number: 10870021
    Abstract: Ambrisentan and formulations thereof for use in the treatment and prevention of acute renal failure associated with renal vasoconstriction.
    Type: Grant
    Filed: March 20, 2017
    Date of Patent: December 22, 2020
    Assignee: NOORIK BIOPHARMACEUTICALS AG
    Inventors: Iker Navarro, Satish Khanna
  • AMBRISENTAN FOR USE IN THE TREATMENT OF ACUTE RENAL FAILURE
    Publication number: 20190083820
    Abstract: Ambrisentan and formulations thereof for use in the treatment and prevention of acute renal failure associated with renal vasoconstriction.
    Type: Application
    Filed: March 20, 2017
    Publication date: March 21, 2019
    Applicant: Noorik Biopharmaceuticals AG
    Inventors: Iker NAVARRO, Satish KHANNA